Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00046_DB00104_nanopub.RAEx790hnsMMdupcvZOXhZF3QRcv4OQJJAfW5YQORZXEs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00046_DB00104 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00046_DB00104 label "DDI between Insulin Lispro and Octreotide - Concomitant therapy with somatostatin analogs may increase the blood-glucose-lowering effect of insulin lispro and thus the chance of hypoglycemia should be monitored closely. [drugbank_resource:DB00046_DB00104]" assertion.
- drugbank_resource:DB00046_DB00104 identifier "drugbank_resource:DB00046_DB00104" assertion.
- drugbank_resource:DB00046_DB00104 title "DDI between Insulin Lispro and Octreotide - Concomitant therapy with somatostatin analogs may increase the blood-glucose-lowering effect of insulin lispro and thus the chance of hypoglycemia should be monitored closely." assertion.
- drugbank:DB00046 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00046_DB00104 assertion.
- drugbank:DB00104 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00046_DB00104 assertion.